BindingDB logo
myBDB logout

BDBM50231882 CHEMBL4075157

SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCC(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O

InChI Key: InChIKey=OGKIYPYMXDSAIK-FSNAXOAFSA-N

Data: 1 KI  2 EC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50231882   
Target/Host
(Institution)		LigandTarget/Host
Links		Ligand
Links		Trg + Lig
Links		Ki
nM		ΔG°
kcal/mole		IC50
nM		Kd
nM		EC50/IC50
nM		koff
s-1		kon
M-1s-1		pHTemp
°C
Glucagon-like peptide 1 receptor


(Homo sapiens (Human))		BDBM50231882
PNG
(CHEMBL4075157)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCC(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O |r|
Show InChI InChI=1S/C152H227N41O46/c1-16-78(10)123(150(238)170-82(14)128(216)180-105(61-87-64-161-91-35-24-23-34-90(87)91)140(228)182-101(57-75(4)5)141(229)190-121(76(6)7)148(236)179-93(36-25-27-53-153)130(218)163-67-114(202)171-92(38-29-55-160-152(157)158)129(217)162-66-112(156)200)192-142(230)103(58-84-30-19-17-20-31-84)184-136(224)99(47-52-119(209)210)178-134(222)94(37-26-28-54-154)175-126(214)80(12)167-125(213)79(11)168-133(221)97(43-48-111(155)199)172-115(203)68-165-132(220)96(46-51-118(207)208)177-138(226)100(56-74(2)3)181-139(227)102(60-86-39-41-89(198)42-40-86)185-145(233)108(70-194)187-147(235)110(72-196)188-149(237)122(77(8)9)191-144(232)107(63-120(211)212)186-146(234)109(71-195)189-151(239)124(83(15)197)193-143(231)104(59-85-32-21-18-22-33-85)183-135(223)98-44-49-113(201)174-106(62-88-65-159-73-166-88)137(225)169-81(13)127(215)176-95(45-50-117(205)206)131(219)164-69-116(204)173-98/h17-24,30-35,39-42,64-65,73-83,92-110,121-124,161,194-198H,16,25-29,36-38,43-63,66-72,153-154H2,1-15H3,(H2,155,199)(H2,156,200)(H,159,166)(H,162,217)(H,163,218)(H,164,219)(H,165,220)(H,167,213)(H,168,221)(H,169,225)(H,170,238)(H,171,202)(H,172,203)(H,173,204)(H,174,201)(H,175,214)(H,176,215)(H,177,226)(H,178,222)(H,179,236)(H,180,216)(H,181,227)(H,182,228)(H,183,223)(H,184,224)(H,185,233)(H,186,234)(H,187,235)(H,188,237)(H,189,239)(H,190,229)(H,191,232)(H,192,230)(H,193,231)(H,205,206)(H,207,208)(H,209,210)(H,211,212)(H4,157,158,160)/t78-,79-,80-,81-,82-,83+,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,121-,122-,123-,124-/m0/s1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars
PubMed
>50n/an/an/an/an/an/an/an/a



The University of Queensland

Curated by ChEMBL


Assay Description
Displacement of [125I]-GLP (7 to 36 residues) from human GLP1R expressed in CHO cell membranes incubated for 30 mins measured after 10 hrs by scintil...

Eur J Med Chem 127: 703-714 (2017)


BindingDB Entry DOI: 10.7270/Q2T155W1
More data for this
Ligand-Target Pair
Glucagon-like peptide 1 receptor


(Homo sapiens (Human))		BDBM50231882
PNG
(CHEMBL4075157)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCC(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O |r|
Show InChI InChI=1S/C152H227N41O46/c1-16-78(10)123(150(238)170-82(14)128(216)180-105(61-87-64-161-91-35-24-23-34-90(87)91)140(228)182-101(57-75(4)5)141(229)190-121(76(6)7)148(236)179-93(36-25-27-53-153)130(218)163-67-114(202)171-92(38-29-55-160-152(157)158)129(217)162-66-112(156)200)192-142(230)103(58-84-30-19-17-20-31-84)184-136(224)99(47-52-119(209)210)178-134(222)94(37-26-28-54-154)175-126(214)80(12)167-125(213)79(11)168-133(221)97(43-48-111(155)199)172-115(203)68-165-132(220)96(46-51-118(207)208)177-138(226)100(56-74(2)3)181-139(227)102(60-86-39-41-89(198)42-40-86)185-145(233)108(70-194)187-147(235)110(72-196)188-149(237)122(77(8)9)191-144(232)107(63-120(211)212)186-146(234)109(71-195)189-151(239)124(83(15)197)193-143(231)104(59-85-32-21-18-22-33-85)183-135(223)98-44-49-113(201)174-106(62-88-65-159-73-166-88)137(225)169-81(13)127(215)176-95(45-50-117(205)206)131(219)164-69-116(204)173-98/h17-24,30-35,39-42,64-65,73-83,92-110,121-124,161,194-198H,16,25-29,36-38,43-63,66-72,153-154H2,1-15H3,(H2,155,199)(H2,156,200)(H,159,166)(H,162,217)(H,163,218)(H,164,219)(H,165,220)(H,167,213)(H,168,221)(H,169,225)(H,170,238)(H,171,202)(H,172,203)(H,173,204)(H,174,201)(H,175,214)(H,176,215)(H,177,226)(H,178,222)(H,179,236)(H,180,216)(H,181,227)(H,182,228)(H,183,223)(H,184,224)(H,185,233)(H,186,234)(H,187,235)(H,188,237)(H,189,239)(H,190,229)(H,191,232)(H,192,230)(H,193,231)(H,205,206)(H,207,208)(H,209,210)(H,211,212)(H4,157,158,160)/t78-,79-,80-,81-,82-,83+,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,121-,122-,123-,124-/m0/s1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars
PubMed
n/an/an/an/a>1.00E+4n/an/an/an/a



The University of Queensland

Curated by ChEMBL


Assay Description
Agonist activity at human GLP1R expressed in CHOK1 cells assessed as induction of beta-galactosidase-tagged beta-arrestin2 recruitment incubated for ...

Eur J Med Chem 127: 703-714 (2017)


BindingDB Entry DOI: 10.7270/Q2T155W1
More data for this
Ligand-Target Pair
Glucagon-like peptide 1 receptor


(Homo sapiens (Human))		BDBM50231882
PNG
(CHEMBL4075157)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCC(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O |r|
Show InChI InChI=1S/C152H227N41O46/c1-16-78(10)123(150(238)170-82(14)128(216)180-105(61-87-64-161-91-35-24-23-34-90(87)91)140(228)182-101(57-75(4)5)141(229)190-121(76(6)7)148(236)179-93(36-25-27-53-153)130(218)163-67-114(202)171-92(38-29-55-160-152(157)158)129(217)162-66-112(156)200)192-142(230)103(58-84-30-19-17-20-31-84)184-136(224)99(47-52-119(209)210)178-134(222)94(37-26-28-54-154)175-126(214)80(12)167-125(213)79(11)168-133(221)97(43-48-111(155)199)172-115(203)68-165-132(220)96(46-51-118(207)208)177-138(226)100(56-74(2)3)181-139(227)102(60-86-39-41-89(198)42-40-86)185-145(233)108(70-194)187-147(235)110(72-196)188-149(237)122(77(8)9)191-144(232)107(63-120(211)212)186-146(234)109(71-195)189-151(239)124(83(15)197)193-143(231)104(59-85-32-21-18-22-33-85)183-135(223)98-44-49-113(201)174-106(62-88-65-159-73-166-88)137(225)169-81(13)127(215)176-95(45-50-117(205)206)131(219)164-69-116(204)173-98/h17-24,30-35,39-42,64-65,73-83,92-110,121-124,161,194-198H,16,25-29,36-38,43-63,66-72,153-154H2,1-15H3,(H2,155,199)(H2,156,200)(H,159,166)(H,162,217)(H,163,218)(H,164,219)(H,165,220)(H,167,213)(H,168,221)(H,169,225)(H,170,238)(H,171,202)(H,172,203)(H,173,204)(H,174,201)(H,175,214)(H,176,215)(H,177,226)(H,178,222)(H,179,236)(H,180,216)(H,181,227)(H,182,228)(H,183,223)(H,184,224)(H,185,233)(H,186,234)(H,187,235)(H,188,237)(H,189,239)(H,190,229)(H,191,232)(H,192,230)(H,193,231)(H,205,206)(H,207,208)(H,209,210)(H,211,212)(H4,157,158,160)/t78-,79-,80-,81-,82-,83+,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,121-,122-,123-,124-/m0/s1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars
PubMed
n/an/an/an/a>1.00E+4n/an/an/an/a



The University of Queensland

Curated by ChEMBL


Assay Description
Agonist activity at human GLP1R expressed in CHO cells assessed as cAMP accumulation incubated for 30 mins by LANCE assay

Eur J Med Chem 127: 703-714 (2017)


BindingDB Entry DOI: 10.7270/Q2T155W1
More data for this
Ligand-Target Pair